Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Cell > ASGR1&ASGR2 > CHEK-ATP172

HEK293/Human ASGR1&ASGR2 Stable Cell Line

Order Now

  • Description
    The HEK293/Human ASGR1&ASGR2 Stable Cell Line was engineered to express the receptors full length human ASGR1 (Gene ID: 432) and ASGR2 (Gene ID: 433). Surface expression of human ASGR1 and ASGR2 was confirmed by flow cytometry.
  • Application

    • Useful for cell-based ASGR1 or ASGR2 binding assay

  • Growth Properties
  • Selection Marker
    Puromycin (2 μg/mL) + Hygromycin (10 μg/mL)
  • Culture Medium
    DMEM + 10% FBS
  • Freeze Medium
    Serum-free cell cryopreservation medium
  • Quantity
    1 vial contains at least 5×10^6 cells in 1 mL serum-free cryopreservation medium
  • Storage
    Frozen in liquid nitrogen.
  • Mycoplasma Testing
  • Sterility Testing
  • Instructions for Use
    See data sheet for detailed culturing and assay protocol.

Co-expression analysis of human ASGR1 and ASGR2 on HEK293/Human ASGR1&ASGR2 Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Human ASGR1&ASGR2 Stable Cell Line or negative control cell using APC-labeled anti-ASGR1 antibody and PE-labeled anti-ASGR2 antibody.

  • Background
    ASGPR, a transmembrane C-type lectin, recognizes a wide variety of ligands that contain either terminal galactose (Gal) or N-acetylgalactosamine (GalNAc) residues and has been identified as a highly selective receptor on hepatocytes. The ASGR is composed of both a major (ASGR1) and minor subunit (ASGR2).
  • License Disclosure
    This cell line is provided for research use only. This license does not permit you to share, distribute, sell, sublicense, or otherwise make this cell line available for use to other laboratories, departments, research institutions, hospitals, universities, or biotech companies. The license does not permit modification of this cell line in any way. Inappropriate use or distribution of this cell line will result in revocation of the license. Modifications of this cell line, transfer to another facility, or commercial use of the cell lines may require a separate license and additional fees. AcroBiosystems does not warrant the suitability of this cell line for any particular use, and does not accept any liability in connection with the handling or use of this cell line.
  • Clinical and Translational Updates

Comments (0)

ETD of in-stock products: 2 business days

Price(USD) : $3500.00

Promotion & Exhibitions

Datasheet & Documentation

Related Products

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message